U-GENE

Multi-national network of excellence for research on genetic predisposition to cardio-metabolic disorders due to UCP1 gene polymorphisms

Coordinatore	ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS    more  Organization address address: CHARILAOU THERMI ROAD 6 KM city: THERMI THESSALONIKI postcode: 57001 contact info Titolo: Mrs. Nome: Georgia Cognome: Pahlitzanakis Email: send email Telefono: 302421000000 Fax: 302421000000
Nazionalità Coordinatore	Greece [EL]
Totale costo	410˙400 €
EC contributo	410˙400 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2012-IRSES
Funding Scheme	MC-IRSES
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-08-01   -   2017-07-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS  Organization address address: CHARILAOU THERMI ROAD 6 KM city: THERMI THESSALONIKI postcode: 57001 contact info Titolo: Mrs. Nome: Georgia Cognome: Pahlitzanakis Email: send email Telefono: 302421000000 Fax: 302421000000	EL (THERMI THESSALONIKI)	coordinator	148˙200.00
2	INSTYTUT IMMUNOLOGII I TERAPII DOSWIADCZALNEJ IM LUDWIKA HIRSZFELDA PAN  Organization address address: UL. R. WEIGLA 12 city: WROCLAW postcode: 53-114 contact info Titolo: Ms. Nome: Anna Cognome: Polanska Email: send email Telefono: 48713373490	PL (WROCLAW)	participant	148˙200.00
3	UNIVERSITY OF WOLVERHAMPTON  Organization address address: WULFRUNA STREET city: WOLVERHAMPTON postcode: WV1 1LY contact info Titolo: Dr. Nome: George Cognome: Metsios Email: send email Telefono: 441902000000	UK (WOLVERHAMPTON)	participant	114˙000.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Cardio-metabolic disorders (CMD) represent a heavy public health burden for Europe which has one of the highest adult mortality rates in the world, primarily due to a very high incidence of CMD. The 2011 FP7 Health Work Programme included three Calls targeted specifically on understanding CMD nature and pathophysiology, while the World Health Organization Regional Office for Europe recently recognised CMD as the greatest public health challenge of the 21st century. The aim of this proposal is to create a multiannual joint programme of collaboration between eminent research entities based in EU or Associated Countries (EU/AC) and Eastern Europe and Central Asia (EECA) countries for investigating the prevalence of uncoupling protein one genetic polymorphisms and their impact on predisposition to CMD. Thus, U-GENE fits perfectly within the scope of IRSES which aims in establishing long-term research cooperations through coordinated joint programmes of balanced research staff exchanges in thematic areas that are relevant to the European population. In addition, the EECA region is of strategic importance to the EU, in both economic (trade, energy) and political (security, stability) terms. The U-GENE partners boast an outstanding group of researchers, extensive collaboration and knowledge transfer networks, a large number of relevant publications, as well as very active participation in research programs funded by the European Commission. Moreover, the partners’ experience and specialisation in CMD research, their extensive experience in networks of excellence and international collaborations, and their broad infrastructures will provide the level of quality required to transform the U-GENE joint exchange programme into a successful multi-national network of excellence for CMD research.'